Oral Drug Delivery Resources

  1. Procuring Packaging And Delivery Systems: Single Versus Dual Sourcing 6/2/2026

    In this article, Fran DeGrazio examines the trend toward dual sourcing of products, components, and materials for drug delivery packaging and systems. She outlines the key differences between single and dual sourcing and makes recommendations about using one versus the other while mitigating supply chain and product quality risk. 

  2. Nanoformed API: A Superior Alternative To Solid Dispersions 7/29/2024

    Cutting-edge nanotechnology is now emerging, able to address bioavailability challenges and deliver higher drug loads in more patient-friendly formats with fewer and smaller pills and easier regimens.

  3. Seven Softgel Myths: Are You Missing Your Softgel Opportunity?

    Softgels are a popular dose format among consumers, thanks to their high swallowability and quick onset of action, yet pharmaceutical developers may not even consider them. Why the disconnect?

  4. Combining Powdose® And Diffucaps® For Precise Solid Oral Dosing 6/30/2025

    Combining POWDOSE® and Diffucaps® enables precise, individualized solid oral dosing—improving drug delivery, patient compliance, and therapeutic outcomes in personalized medicine applications.

  5. Partnering For Success In Sustained Drug Delivery Formulations 3/18/2022

    With a focus on the sustained and controlled drug delivery segment of the pharmaceutical market, learn about technology platforms, support services, and sustainable solutions.

  6. Leveraging Tools To Create Optimized Solutions 7/17/2024

    Review the key trends and challenges shaping the CDMO industry as well as the tools helping a leading CDMO meet the growing demand for pediatric formulations and taste-masking solutions.

  7. Key Offerings To Support Your OSD On Its Journey To Market

    Examine several important factors needed to effectively support oral solid dosage therapeutic manufacturing and overcome the complexities involved.

  8. Aligning Pediatric Patient Needs With Drug Development Success 8/15/2024

    Executive Director of Pharmaceutical Sciences Srinivasan Shanmugam, Ph.D., discusses pediatric patient compliance, regulations impacting trial access, excipients within formulations, and more.

  9. Diagnose Absorption Risks To Improve Preclinical And Clinical Outcomes 8/8/2023

    Physiologically based pharmacokinetic modeling is a powerful tool for clinical trial design that can be leveraged alongside early development experiments to reduce costs and accelerate timelines.

  10. How Various Clinical Study Stages Influence Oral Formulation Approach 4/6/2022

    It’s important for pharmaceutical and biopharmaceutical companies to implement a phase-appropriate approach for early formulation development and later-stage commercial development.